Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation

Research output: Contribution to journalArticle

Abstract

Systemic lupus erythematosus (SLE), a disorder of the immune system, is potentially curable by allogeneic bone marrow transplantation (alloBMT). Until recently, alloBMT was limited by donor availability and toxicity. Reduced intensity conditioning (RIC) combined with post-transplantation cyclophosphamide (PTCy) has improved the availability and safety of alloBMT permitting its exploration in severe-refractory autoimmune illnesses. We report the six-year follow-up of a young female whose refractory SLE-associated nephrosis resolved after RIC alloBMT with PTCy.

Original languageEnglish (US)
Pages (from-to)773-776
Number of pages4
JournalLupus
Volume26
Issue number7
DOIs
StatePublished - 2017

Keywords

  • Systemic lupus erythematosus
  • alloBMT

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation'. Together they form a unique fingerprint.

  • Cite this